EpiEndo Pharmaceuticals raised €20M in a Series A round in Aug 2021. The company is based in Reykjavík, Iceland. Investors in the round: Iðunn Venture Fund, ABC Ventures, European Innovation Council (EIC) and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €20M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
